Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020

SELL
$98.9 - $178.34 $1.04 Million - $1.88 Million
-10,555 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$126.05 - $152.76 $1.33 Million - $1.61 Million
10,555 New
10,555 $1.61 Million
Q4 2017

Feb 12, 2018

SELL
$100.43 - $118.09 $291,247 - $342,461
-2,900 Closed
0 $0
Q3 2017

Oct 16, 2017

SELL
$96.72 - $109.26 $251,472 - $284,076
-2,600 Reduced 47.27%
2,900 $313,000
Q2 2017

Aug 10, 2017

BUY
N/A
5,500
5,500 $556,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.